ATE428470T1 - Heilmittel zur behandlung von erkrankungen des sehnervs - Google Patents
Heilmittel zur behandlung von erkrankungen des sehnervsInfo
- Publication number
- ATE428470T1 ATE428470T1 AT01945674T AT01945674T ATE428470T1 AT E428470 T1 ATE428470 T1 AT E428470T1 AT 01945674 T AT01945674 T AT 01945674T AT 01945674 T AT01945674 T AT 01945674T AT E428470 T1 ATE428470 T1 AT E428470T1
- Authority
- AT
- Austria
- Prior art keywords
- optic nerve
- remedies
- treating diseases
- medicament
- therapeutic
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/415—1,2-Diazoles
- A61K31/4152—1,2-Diazoles having oxo groups directly attached to the heterocyclic ring, e.g. antipyrine, phenylbutazone, sulfinpyrazone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A61P27/06—Antiglaucoma agents or miotics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P39/00—General protective or antinoxious agents
- A61P39/06—Free radical scavengers or antioxidants
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Epidemiology (AREA)
- Organic Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Ophthalmology & Optometry (AREA)
- Engineering & Computer Science (AREA)
- Biomedical Technology (AREA)
- Biochemistry (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Toxicology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2000197250 | 2000-06-29 | ||
| PCT/JP2001/005585 WO2002000260A1 (fr) | 2000-06-29 | 2001-06-28 | Jp0105585atif contre des maladies du nerf optique et analogue |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE428470T1 true ATE428470T1 (de) | 2009-05-15 |
Family
ID=18695597
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT01945674T ATE428470T1 (de) | 2000-06-29 | 2001-06-28 | Heilmittel zur behandlung von erkrankungen des sehnervs |
Country Status (8)
| Country | Link |
|---|---|
| US (2) | US20030109566A1 (de) |
| EP (1) | EP1297849B1 (de) |
| JP (1) | JPWO2002000260A1 (de) |
| AT (1) | ATE428470T1 (de) |
| AU (1) | AU2001267864A1 (de) |
| CA (1) | CA2414586C (de) |
| DE (1) | DE60138385D1 (de) |
| WO (1) | WO2002000260A1 (de) |
Families Citing this family (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP4302990B2 (ja) | 2001-05-11 | 2009-07-29 | 田辺三菱製薬株式会社 | 安定かつ高濃度であるピラゾロン誘導体を含む注射剤 |
| CA2484512C (en) | 2002-05-17 | 2013-04-16 | Othera Pharmaceuticals, Inc. | Treatment of cataracts and other ophthalmic diseases |
| WO2004041270A1 (ja) * | 2002-11-05 | 2004-05-21 | Lead Chemical Co.,Ltd. | ３−メチル−１−フェニル−２−ピラゾリン−５−オン含有経皮吸収製剤 |
| US7825134B2 (en) | 2003-05-19 | 2010-11-02 | Othera Holding, Inc. | Amelioration of cataracts, macular degeneration and other ophthalmic diseases |
| KR20070040326A (ko) * | 2003-11-20 | 2007-04-16 | 오쎄라 파마슈티걸즈, 인크. | 백내장, 황반 변성 및 다른 안과 질환의 개선 |
| WO2007055312A1 (ja) * | 2005-11-10 | 2007-05-18 | Mitsubishi Tanabe Pharma Corporation | ピラゾロン化合物含有水溶液が充填されたプラスチック容器 |
| AU2008326593B2 (en) * | 2007-11-21 | 2013-09-05 | Techno Guard Co. Ltd. | Pyrazolone derivative emulsion formulations |
| JP5591720B2 (ja) | 2009-01-29 | 2014-09-17 | 株式会社林原 | 抗神経変性疾患剤 |
| JP2017222575A (ja) | 2014-09-19 | 2017-12-21 | 田辺三菱製薬株式会社 | 眼科疾患予防治療剤 |
Family Cites Families (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE3533662A1 (de) * | 1984-09-20 | 1986-03-27 | Medice Chem.-Pharm. Fabrik Pütter GmbH & Co KG, 5860 Iserlohn | Kombination von 1-phenyl-4-alkylpyrazolidindion-3,5-derivaten mit einem starken reduktionsmittel fuer die herstellung eines topischen entzuendungshemmenden arzneimittels fuer augen |
| DK169672B1 (da) * | 1985-05-20 | 1995-01-09 | Mitsubishi Chem Ind | Farmaceutiske præparater indeholdende pyrazolonderivater som aktiv bestanddel og anvendelsen af pyrazolonderivater til fremstilling af farmaceutiske præparater |
| JPS62108814A (ja) | 1985-11-07 | 1987-05-20 | Mitsubishi Chem Ind Ltd | 過酸化脂質生成抑制剤 |
| JPS61263917A (ja) | 1985-05-20 | 1986-11-21 | Mitsubishi Yuka Yakuhin Kk | 脳機能正常化剤 |
| FR2608045B1 (fr) | 1986-12-12 | 1990-03-02 | Chauvin Laboratoires | Utilisation d'inhibiteurs de xanthine- oxydase, de piegeurs de radicaux libres oxygenes et de chelateurs du fer pour la fabrication d'une composition pharmaceutique destinee au traitement du glaucome et compositions pharmaceutiques destinees au traitement du glaucome |
| JP2906512B2 (ja) * | 1990-01-16 | 1999-06-21 | 三菱化学株式会社 | 抗潰瘍剤 |
| WO1993000088A1 (de) * | 1991-06-24 | 1993-01-07 | Hoechst Aktiengesellschaft | Verwendung von phenylpyrazolin-derivaten zur behandlung von erhöhtem augeninnendruck |
| TW325997B (en) * | 1993-02-02 | 1998-02-01 | Senju Pharma Co | Pharmaceutical composition for preventing and treating retinal diseases |
| JPH0725765A (ja) * | 1993-07-07 | 1995-01-27 | Mitsubishi Chem Corp | 眼疾患用薬剤 |
| JPH09278652A (ja) * | 1996-04-05 | 1997-10-28 | Sumitomo Pharmaceut Co Ltd | 網膜疾患治療剤 |
| GB9701710D0 (en) * | 1997-01-28 | 1997-03-19 | Karobio Ab | Mammalian protein |
| JPH10218771A (ja) * | 1997-02-05 | 1998-08-18 | Ishihara Sangyo Kaisha Ltd | ピラゾロン系化合物またはその塩を含有する血小板由来血管内皮細胞増殖因子活性阻害剤 |
-
2001
- 2001-06-28 JP JP2002505041A patent/JPWO2002000260A1/ja active Pending
- 2001-06-28 DE DE60138385T patent/DE60138385D1/de not_active Expired - Fee Related
- 2001-06-28 AU AU2001267864A patent/AU2001267864A1/en not_active Abandoned
- 2001-06-28 WO PCT/JP2001/005585 patent/WO2002000260A1/ja active Search and Examination
- 2001-06-28 CA CA002414586A patent/CA2414586C/en not_active Expired - Fee Related
- 2001-06-28 US US10/312,502 patent/US20030109566A1/en not_active Abandoned
- 2001-06-28 EP EP01945674A patent/EP1297849B1/de not_active Expired - Lifetime
- 2001-06-28 AT AT01945674T patent/ATE428470T1/de not_active IP Right Cessation
-
2006
- 2006-06-30 US US11/477,854 patent/US7638516B2/en not_active Expired - Fee Related
Also Published As
| Publication number | Publication date |
|---|---|
| EP1297849A4 (de) | 2006-10-18 |
| AU2001267864A1 (en) | 2002-01-08 |
| JPWO2002000260A1 (ja) | 2004-01-08 |
| US7638516B2 (en) | 2009-12-29 |
| US20060247293A1 (en) | 2006-11-02 |
| CA2414586A1 (en) | 2002-12-30 |
| WO2002000260A1 (fr) | 2002-01-03 |
| CA2414586C (en) | 2009-09-29 |
| US20030109566A1 (en) | 2003-06-12 |
| DE60138385D1 (de) | 2009-05-28 |
| EP1297849A1 (de) | 2003-04-02 |
| EP1297849B1 (de) | 2009-04-15 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ATE426413T1 (de) | Verfahren und zusammensetzungen zur behandlung von okularer neovaskularisierung und nervenverletzungen | |
| ATE254461T1 (de) | Behandlung von augenschmerzen | |
| BR0108175A (pt) | Derivados de piperazina e piperidina para o tratamento ou a prevenção de danos neuronais | |
| DE502005001828D1 (de) | Verwendung von rotigotin zur behandlung und prävention des parkinson-plus-syndroms | |
| SE9803710D0 (sv) | Use of certain drugs for treating nerve root injury | |
| ATE445405T1 (de) | Vorbeugung und behandlung von oxidativer-stress- erkrankungen mit verbindungen die den intrazellulären spiegel von glutathion oder phase-ii-entgiftungsenzymen erhöhen | |
| DE60142839D1 (de) | Botulinum Toxin zur Behandlung von akuten Verletzungen der Skelettmuskeln | |
| BR0210241A (pt) | Piranoindazóis e seu uso no tratamento de glaucoma | |
| WO2004096216A3 (en) | Use of a topical medicament comprising riluzole | |
| ATE533486T1 (de) | Verwendung von pyridonderivaten zur vorbeugung und behandlung von strahlungsbedingter lungenverletzung | |
| EA200300560A1 (ru) | Улучшенный способ лечения | |
| ATE375141T1 (de) | Verfahren und mittel zur behandlung und vorbeugung von erkrankungen der hinteren augenkammer | |
| ATE435026T1 (de) | Verfahren zur prävention und behandlung von diabetes mit neurturin | |
| ATE428470T1 (de) | Heilmittel zur behandlung von erkrankungen des sehnervs | |
| DE60231246D1 (de) | Superoxiddismutas-mimetika zur behandlung von augenerkrankungen | |
| BR9915569A (pt) | Método para o tratamento de doenças neovasculares oculares | |
| BR0113201A (pt) | processo para tratar distúrbios neurodegenerativos da retina e da cabeça do nervo óptico | |
| ATE359808T1 (de) | Verwendung von sarp-1 zur behandlung und/oder vorbeugung von scleroderma | |
| BR0309611A (pt) | ácidos aminoalcanofosfÈnicos substituìdos para o tratamento da dor neuropática, dos distúrbios afetivos e da atenção, da esquizofrenia, do zumbido no ouvido, da miopia e de outros distúrbios oculares. | |
| MXPA04001255A (es) | Uso de compuesto para el tratamiento de condiciones que resultan de lesion al nervio corneo despues de lasik y otras cirugias oculares o trauma. | |
| ATE448779T1 (de) | Methode zur behandlung trockener augen und uveitis | |
| DE60231994D1 (de) | Mittel zur behandlung oder prävention allergischerg | |
| DE60109594D1 (de) | R-eliprodil zur behandlung von glaucoma | |
| BRPI0417549A (pt) | miméticos de superóxido dismutase para o tratamento de lesão de nervo óptico e retinal | |
| BR0215752A (pt) | Piranoindazóis e seu uso no tratamento de glaucoma |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| RER | Ceased as to paragraph 5 lit. 3 law introducing patent treaties |